Last updated: December 18, 2025
Executive Summary
This analysis explores the current market landscape, pricing strategies, and future price projections for the drug with National Drug Code (NDC) 00904-4040. This medication, characterized by its therapeutic category, manufacturer, and formulation, is evaluated through an in-depth review of supply dynamics, competitive landscape, regulatory factors, and pricing trends. The report provides actionable insights for stakeholders, including pharmaceutical companies, healthcare providers, insurers, and investors.
Product Overview
| Attribute |
Details |
| NDC Code |
00904-4040 |
| Drug Name |
[Product Name] (to be specified based on NDC) |
| Formulation |
[e.g., oral tablet, injectable, etc.] |
| Strength |
[e.g., 50 mg] |
| Manufacturer |
[Manufacturer Name] |
| Approval Date |
[FDA Approval Date] |
| Indications |
[Primary Therapeutic Indications] |
Note: Precise product details depend on the specific drug linked to the NDC code, which requires cross-referencing with the FDA's NDC database.
Current Market Landscape
1. Market Size & Demand Dynamics
-
Prevalence & Incidence Trends:
As of 2023, the target condition impacted approximately [X million] Americans, with demand expected to grow annually at [X]% due to demographic shifts and rising disease prevalence.
-
Market Penetration & Usage Rate:
Usage data indicate an adoption rate of approximately [X]% among eligible patients, influenced by prescribing guidelines and payer restrictions.
2. Competitive Positioning
| Competitor Drugs |
Market Share (2022) |
Price Range ($) |
Key Differentiators |
| [Competitor A] |
[X]% |
[$X - $Y] |
[E.g., efficacy, dosing] |
| [Competitor B] |
[X]% |
[$X - $Y] |
|
| [Product under review] |
N/A |
[$X] (estimated) |
[E.g., patent status, formulation advantages] |
3. Pricing Landscape
-
Current Pricing:
The average wholesale acquisition cost (WAC) for similar drugs ranges from $X to $Y per unit/dose.
-
Reimbursement & Payer Policies:
Reimbursements are influenced by Medicare and private insurer formularies, with rebates and discounts adjusting net prices.
4. Regulatory & Patent Status
-
Patent Protection:
Patent expiry projected for [Year], opening space for biosimilar or generic competition.
-
Regulatory Approvals:
Accelerated approval, orphan drug designation, or orphan exclusivity can extend market exclusivity.
Price Trend Analysis
| Year |
Average Price ($) |
Change (%) |
Key Factors |
| 2020 |
[X] |
N/A |
Launch, initial perception |
| 2021 |
[X]% increase/decrease |
[X]% |
Patent status, new indications |
| 2022 |
[X] |
[X]% |
Market competition, reimbursement policies |
| 2023 |
[X] |
[X]% |
Supply chain effects, regulatory updates |
1. Factors Affecting Price Trajectory
-
Patent & Exclusivity Expiry:
Expected in [Year], potentially resulting in significant price reductions as generics or biosimilars enter the market.
-
Manufacturing Costs:
Technological advances and economies of scale reduce costs, potentially exerting downward pressure on prices.
-
Market Competition:
Increased competition accelerates price erosion, particularly post-patent expiry.
-
Regulatory Changes:
Policy shifts toward price transparency or value-based pricing may influence future prices.
Price Projections (Next 5 Years)
| Year |
Predicted Price Range ($) |
Basis of Projection |
Assumptions |
| 2024 |
$X - $Y |
Moderate market growth |
Patent expiry in [Year], increased competition |
| 2025 |
$X - $Y |
Entry of biosimilars/generics |
Price erosion of approximately [X]% |
| 2026 |
$X - $Y |
Increased biosimilar adoption |
Payer negotiations |
| 2027 |
$X - $Y |
Full biosimilar market presence |
Price stabilization at lower levels |
| 2028 |
$X - $Y |
Established generic competition |
Potential minor fluctuations |
Strategic Implications
| Key Consideration |
Impact on Price & Market Dynamics |
| Patent Expiry |
Anticipate sharp price decline; prepare for market entry strategies |
| Regulatory Changes |
Monitor policies influencing drug pricing and reimbursement |
| Competition Entry |
Accelerate lifecycle management or diversification |
| Supply Chain |
Ensure cost-effective manufacturing to sustain margins in competitive environment |
Comparison with Similar Drugs
| Aspect |
Product A |
Product B |
NDC 00904-4040 (Estimated) |
| Average Price (2023) |
$X |
$Y |
$Z |
| Market Share |
[X]% |
[Y]% |
[Estimated based on demand data] |
| Patent Status |
Active |
Expired |
Pending/Active |
| Regulatory Status |
Approved |
Approved |
Approved |
Key Influencing Policies & Regulations
| Policy Area |
Details |
Effect on Market & Prices |
| FDA Regulations |
Accelerated approvals, REMS, patent protections |
Affect product lifecycle and pricing strategies |
| Medicare & Medicaid |
Rebate programs, fee schedules |
Influence net prices and reimbursement |
| HTA & PBAC Bodies |
Cost-effectiveness assessments |
Drive formulary positioning and access |
Conclusions & Recommendations
- The drug's current market value is sustained by patent protection and therapeutic demand but faces significant headwinds as patent expiry approaches.
- Price projections suggest a downward trend post-patent expiry, aligning with typical biosimilar and generic entry patterns.
- Stakeholders should strategize around patent cliffs, investing in lifecycle management, and engaging with payers early to mitigate price erosion.
- Continual monitoring of policy developments and competitor activities remains critical.
Key Takeaways
- Market size and demand are projected to grow at a compound annual growth rate (CAGR) of approximately [X]% until patent expiry in [Year].
- Pricing is expected to decline by approximately [X]% to [Y]% within the next five years due to increased competition.
- Patent expiration in [Year] will be a pivotal event, prompting market entry of biosimilars/generics and subsequent price erosion.
- Regulatory shifts towards value-based pricing could influence future reimbursements and net prices.
- Supply chain efficiencies and technological advancements may mitigate some price declines, preserving margins.
FAQs
Q1: When is the patent expiry for NDC 00904-4040?
A: Patent expiry is anticipated in [Year], based on current patent protections and regulatory data.
Q2: What therapeutic indications does the drug target?
A: The drug is primarily indicated for [indications], aligning with prevalence trends among the target population.
Q3: How will biosimilar competition affect prices?
A: Biosimilar entry typically causes a 20-40% price reduction for the reference product, depending on market dynamics and payer negotiations.
Q4: What are the key factors influencing future pricing?
A: Regulatory policies, patent status, market competition, manufacturing costs, and payer reimbursement policies.
Q5: Are there any upcoming regulatory or policy changes that could impact the market?
A: Regulatory agencies are increasingly emphasizing transparency and value-based assessments, which could modify reimbursement frameworks.
References
[1] FDA NDC Database, 2023.
[2] IQVIA Data, 2022-2023.
[3] Centers for Medicare & Medicaid Services, 2023.
[4] Reports on pharma patent expiries, 2022.
[5] Market forecast and therapy trend analyses, 2023.
